InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,316.00
(
0.93%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.81%
)
Bitcoin
68,914.85
(
1.46%
)
Post# of 251933
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ggwpq

Send PM Follow Ignore
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

ggwpq

Re: Mufaso post# 250732

Tuesday, 02/27/2024 7:17:28 AM

Tuesday, February 27, 2024 7:17:28 AM

Post# of 251933
Congrats Mufaso! Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity


https://ir.vikingtherapeutics.com/2024-02-27-Viking-Therapeutics-Announces-Positive-Top-Line-Results-from-Phase-2-VENTURE-Trial-of-Dual-GLP-1-GIP-Receptor-Agonist-VK2735-in-Patients-with-Obesity
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up